New Jersey A 2324: Codifies certain regulatory provisions regarding controlled dangerous substances and prescription monitoring.

Status: Introduced in the Assembly, Referred to Assembly Health Committee (as of 2020-02-03)

State: New Jersey · Session: 219 · Bill: A 2324

Subjects: DRUG ABUSE, PHARMACEUTIC

Sponsors: Murphy, Carol A., Vainieri Huttle, Valerie

View New Jersey A 2324 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.